SIGN UP
LOG IN
C
01228
CANbridge Pharmaceuticals
0.33
0.12+58.54%Closed16:08 06/13 HKT
OPEN/PREV CLOSE0.191/0.205
TODAY RANGE0.191-0.365
VOL58.46M
MARKET CAP138.07M
52 WEEK RANGE0.095-0.500
AVG VOL (3M)3.69M
% TURNOVER13.76%
TURNOVER17.10M
P/E (TTM)-0.289
% RANGE84.88%
EPS(TTM)-1.125
P/E(FORWARD)-0.509
P/B-0.269
BVPS-1.206
DIVIDEND--
P/S1.503
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP138.07M
SHARES OUTSTANDING424.84M
NEXT EARNINGS--
FREE FLOAT424.84M
LOT SIZE1000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·05/20 04:23
CANBRIDGE PHARMACEUTICALS INC - INJECTION APPROVED BY NMPA
Simply Wall St·04/15 22:28
CANbridge Pharmaceuticals Inc. (HKG:1228) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Reuters·03/31 13:06
CANBRIDGE PHARMACEUTICALS FY ADJUSTED NET INCOME RMB -346.9 MILLION
Simply Wall St·02/23 00:08
CANbridge Pharmaceuticals Inc. (HKG:1228) Surges 36% Yet Its Low P/S Is No Reason For Excitement
Simply Wall St·01/08 22:08
CANbridge Pharmaceuticals Inc. (HKG:1228) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Simply Wall St·11/14/2024 23:54
CANbridge Pharmaceuticals Inc. (HKG:1228) Not Doing Enough For Some Investors As Its Shares Slump 28%
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.